Gene Query: AMER1

Dataset Description Geneva Score
Circular RNA expression signature of low-glucose-treated MIA PaCa-2 cells 27.97
Cancer avatars derived from genetically engineered pluripotent stem cells allow for longitudinal assessment of tumor development 25.26
Global transcriptional analysis and genome-wide analysis of chromatin state in extended pluripotent stem cells, primed pluripotent stem cells, and naïve pluripotent stem cells 21.29
Global transcriptional analysis of human extended pluripotent stem cells, human primed pluripotent stem cells, mouse extended pluripotent stem cells, and mouse embryonic stem cells by RNA-seq 21.29
Oncogenic Serine-Threonine Kinase Receptor Associated Protein Supports Hepatocellular Carcinoma Cell Growth by Enhancing Wnt/β-catenin Signaling 21.01
Transcriptomic profiling of human HAP1 cells before and after nutrient deprivation 18.93
Human HAP1 cells before and after nutrient deprivation 18.93
Gene expression analysis of the impact of TDP-43 knockout in human cells. 17.44
Temporal activation of NR5A2 and RARγ induce functional human naïve pluripotent state via modulating TGFβ pathway 17.4
The stress granule transcriptome reveals principles of mRNA accumulation in stress granules. 17.02
RNA-seq of naive and primed ES cells (NHSM) 13.89
High Resolution Mapping of RNA Polymerases Identifies Mechanisms of Sensitivity and Resistance to BET Inhibitors in t(8;21) AML 13.88
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma 13.78
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma (RNA-Seq) 13.78
FOXD3 is a novel tumor suppressor in lung cancer 13.47
The ribosomal prolyl-hydroxylase OGFOD1 decreases during cardiac differentiation, modulates translation and spliceosomal processes 12.92
Knockout human reveal an essential role for Paternally Expressed 10 (PEG10) in JEG3 cell line development 12.39
Transcriptomic analysis of the effect of trastuzumab in human iPSC-CMs 12.33
Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function 10.42
Activating PAX Gene Family Paralogs to Complement PAX5 Leukemia Driver Mutations 9.39
RNA-seq analyisis of PUM2 knockout cells 9.37
The effect of Abl kinases on non-small cell carcinoma global transcriptome 9.27
Transcriptome splicing analysis in K562 cells expressing rare and private spliceosomal mutations 9.26
Mutant KRAS/BRAF Reprograms the Enhancer Landscape via GATA1 to Drive Chemoresistance 9.21
HuR controls apoptosis and activation response without effects on cytokine 3′ UTRs 8.94
The RNA helicase DDX39B regulates IL7R alternative splicing reducing the risk of Multiple Sclerosis 8.91
TNF response in promyelocytic and granulocytic forms of HL60/S4 cells 8.77
Dynamics of the human and viral m6A RNA methylomes during HIV-1 infection of T cells 8.66
RNA-Seq with and without RNase treatment in PCa cell lines 8.44
RNA Sequencing Reveals Immunosuppressive Role of Anthrax Lethal Toxin in Human Lung Epithelial and Monocytic Cells 8.39
Transcriptome of TNF-a-treated and untreated HeLa cells before and after TFIIB knockdown 8.38
The landscape of alternative splicing in aggressive prostate cancers 8.31
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [HCC1599_RNA-seq] 8.24
Transcriptome analysis of SKI knock-out in HL60 cells 7.84
Combined cistrome and transcriptome analysis of SKI in AML cells identifies SKI as a co-repressor for RUNX1 7.84
The splicing factor RBM25 controls MYC activity in Acute Myeloid Leukemia 7.63
Folliculin regulates mTORC1/2 and WNT pathways in early human pluripotency 7.55
RNA-seq of cancer cell lines treated with T-025 7.19
Canonical poly(A) polymerase activity promotes the decay of a wide variety of mammalian nuclear RNAs 7.1
The Short Isoform of BRD4 Promotes HIV-1 Latency by Engaging Repressive SWI/SNF Chromatin Remodeling Complexes 6.98
Effect of FGF13 depletion on the H460 cell line 6.96
Capturing the biology of mild versus severe disease in a pluripotent stem cell-based model of Familial Dysautonomia 6.67
Transcriptomic analysis of T84 colon carcinoma cell line treated with trametinib, JQ1 or their combination 6.56
Next Generation Sequencing of control (Untreated), PAN injured and Adriamycin injured human podocytes 6.41
List of TIAM1 differentially expressed genes in SW620 cells [RNA-seq] 6.27
The inhibitory effect of TIAM1 on TAZ transcriptional activity and TIAM1 differentially expressed genes 6.27
RNA-Seq in two Ewing sarcoma cell lines: A673 and SKNMC 6.16
Lung adenocarcinoma metastasis is suppressed by the alveolar lineage transcription factors GATA6 and HOPX. 6.15
RNA sequencing of isogenic BRCA2 haploinsufficient vs. wild-type T-ALL cells 6.12
Transcript abundance in A-T-derived iPSC: Comparing isogenic cells to unrelated individual 5.96
Pseudouridylation of tRNA-derived fragments steers translation control in stem cells [Polysome-Seq] 5.95
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia [RNA-seq] 5.63
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia 5.63
4sUDRB-seq: measuring transcription elongation and initiation genomewide 5.6
Gene expression analysis in U251 and U87 cells transduced with NANEP5 vector. 5.57
Regulation of mRNA half-life by an inhibitor of human decapping enzyme Dcp2 following transcription shutoff in HEK293T cells 5.55
Transcriptome Analysis of CircMRPS35 mediated mRNA expression profiles 5.52
Targeting EZH2 in MYCN-amplified Neuroblastoma 5.43
Targeting EZH2 in MYCN-amplified Neuroblastoma [RNA-seq] 5.43
RNA-seq analysis of control and Myc-induced U2OS cells 5.4
Glioblastoma stem cells infected by ZIKA virus 5.36
Entrectinib Resistance in a Neuroblastoma Xenograft Model 5.35
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations [RNA-Seq] 5.34
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations 5.34
Knockdown of FOXP1 promotes the development of lung adenocarcinoma 5.24
Loss of CREBBP results in gene expression repression in lymphoma cells 5.19
Loss of CREBBP results in H3K27Ac loss at enhancers and gene expression repression in lymphoma cells 5.19
Comparison of single-cell transcriptomics quality between unfixed cells and cells that were fixed and mock stained according to the RAID procedure 5.15
LIN28A modulates splicing and gene expression programs in breast cancer cells 5.13
LIN28A modulates splicing and gene expression programs in breast cancer cells [RNA-Seq] 5.13
Nuclear Parkin Regulates Transcriptional Response during Hypoxia 5.02
Silencing SPIB in attached and floating state of H1703 lung cancer cells 5.0
The effect of spontaneous acquisition of an extra chromosome 7 for engineered del(7q) on induced pluripotent stem cells (iPSCs) derived from patients with Shwachman Diamond Syndrome (SDS). 4.92
RNA sequence of mRNA in HUVEC cells after depleting EGFL6 4.91
Heterogeneous nuclear ribonucleoprotein C1/C2 links transcriptional and splicing actions of 1,25-dihydroxyvitamin D 4.82
The RNA binding protein IGF2BP3 promotes hematopoietic progenitor cell proliferation by targeting leukemogenic pathways 4.8
Neurotrophic Tyrosine Kinase Receptor 1 is Epigenetically Regulated by IL-13 and Contributes to Allergic Inflammation 4.77
HOXC6 affects the malignant phenotype of esophageal squamous cell carcinoma cells 4.71
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer 4.7
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer (RNA-seq) 4.7
RNA Sequencing of Human iPS derived Cardiomyocytes 4.7
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 2] 4.68
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements [RNA-seq] 4.62
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements 4.62
Effect of drugs on transcriptomic profiles 4.59
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma [RNA-seq] 4.58
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma 4.58
N6-methyladenosine Recruits HNRNPG for Alternative Splicing Regulation 4.46
The Polycomb Repressor Complex 1 Drives Double-Negative Prostate Cancer Metastasis by Coordinating Stemness and Immune Suppression 4.41
Oncogenic MYC induces a dependency on the spliceosome in human cancer 4.34
miR-450a acts as a tumor suppressor in ovarian cancer by readjusting energy metabolism 4.33
RNA-seq analysis in knockdown Jurkat samples for each factor of TAL1 complex 4.32
Oncogenic roles of ARID5B in T-ALL 4.32
Expansion, in vivo-ex vivo cycling and genetic manipulation of primary human hepatocytes 4.31
Global gene expression profile of dasatinib-resistant RCH-ACV cells 4.29
CHCHD2 gene KO effect in iPSC drived motor neurons 4.27
SHQ1 regulation of RNA splicing is required for T-lymphoblastic leukemia cell survival 4.23
Next generation sequencing analysis of transcriptomes at different timepoints after chlorprothixene treatment in NB4 and Kasumi-1 cells 4.22
Gene expression in GBM with Cav3.2 inhibition 4.2
SIX4 acts as a master regulator of genes associated with the malignant phenotype of non-small cell lung cancer cells 4.2
The m 6 A-methylase complex recruits TREX and regulates mRNA export. 4.2
Transcriptomic analyssis following EHMT1/2 inhibition 4.19
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-Seq] 4.19
MUC1-C Drives Lineage Plasticity in Progression to Neuroendocrine Prostate Cancer 4.07
Identification of the O-GlcNAc-regulated alternative splicing events by performing RNA sequencing on HeLa cells with altered O-GlcNAc level. 4.04
Nucleotide excision repair capacity increases during differentiation of human embryonic carcinoma cells into neurons and muscle cells 3.98
DART-seq: an antibody-free method for global m6A detection 3.97
Genome wide expression change by RNF168 knocking down in MCF-7 cells 3.95
Total RNA-seq in ALL-SIL upon JQ1 inhibition 3.91
An improved method for circular RNA purification that efficiently removes linear RNAs containing G-quadruplexes or structured 3’ ends 3.9
Comparison between THP-1 cells obtained from either ATCC or DSMZ biorepository 3.86
Cooperation between TLX1 and the NUP214-ABL1/STAT5 signaling in T-cell acute lymphoblastic leukemia 3.86
Isolation and sequencing of AGO-bound RNAs reveals characteristics of stem-loop processing in vivo 3.81
Dissecting the dynamics of signaling events in the BMP,WNT and NODAL cascade during self-organized fate patterning in human gastruloids 3.79
CLIC5: a novel ETV6 target gene in childhood acute lymphoblastic leukemia 3.76
Pitfalls in Single Clone CRISPR-Cas9 Mutagenesis to Fine-map Regulatory Intervals 3.76
MLL-AF4 binds directly to a BCL-2 specific enhancer and impacts H3K27 acetylation 3.73
A transcriptome-wide divergence in protein translation scales with LIN28B expression 3.72
NSD2 overexpression links drives clustered chromatin and transcriptional changes in a subset of insulated domains of insulated domains 3.7
Chromatin-informed inference of transcriptional programs in gynecologic cancers [RNA-Seq] 3.68
Chromatin-informed inference of transcriptional programs in gynecologic cancers 3.68
Transcriptome-wide analysis of IL2RA enhancer activation by CRISPRa 3.68
RNA-seq in transgenic cells 3.68
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia 3.67
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia [RNA-seq] 3.67
Global epigenomic reconfiguration during mammalian brain development 3.61
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export II 3.56
Locally transplanted human urine-induced nephron progenitor cells contribute to renal repair in mice kidney with diabetic nephropathy 3.53
LNCaP treated with iBET 3.46
Transcriptome-wide identification of CELF2 functional targets in T cells 3.44
Expression profiling of lncRNAs, miRNAs and mRNAs and their differential expression in leiomyoma using next generation RNA sequencing 3.43
Transcriptome profiling of HepG2 cells upon treatment of the menin-MLL inhibitor MI-503 or DMSO 3.42
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export 3.38
Maintaining iron homeostasis is the key role of lysosomal acidity for cell proliferation 3.35
Global Transcriptome Analyses of Mammalian Terminal Erythroid Differentiation 3.34
The effects of U1 snRNA mutation in chronic lymphocytic leukemia cell lines 3.26
RNA-seq analysis of differentiating human erythroblasts 3.23
Expression profile of LNCaP/AR cells with or without HNF4G expression grown for long term in charcoal stripped-serum (CSS) media 3.23
RNA-seq analysis of human KMT2A rearranged MV4;11 AML cell line treated with DOT1L and/or EZH2 inhibitor 3.22
Nucleoporin-mediated regulation of cell identity genes 3.2
Gene expression profile of HGC27 gastric cancer cell p53 KO and KD 3.18
Evidence for HOXC6 as a potential molecular marker for non-small cell lung cancer 3.14
TRIM28-Regulated Transposon Repression Is Required for Human Germline Competency and Not Primed or Naive Human Pluripotency 3.13
High-throughput sequencing of pluripotent cells 3.11
mRNA expression data from ESCs derived by polar body transfer reconstructed embryos (PBTESCs) 3.11
RNA-seq of UGP2 mutant human embryonic stem cells and in vitro differentiated neural stem cells 3.11
mRNA-sequencing of 293T-no dice transfected with miR-16, miR-214, or KSHV-miR-K6-5p 3.06
FUS mutant human motoneurons transcriptome analysis reveals altered pathways and impairment of microRNA function 3.01
Hepatosplenic T cell lymphoma 3.0
Integrative Genomic and Transcriptomic Analysis Identified Candidate Genes Implicated in the Pathogenesis of Hepatosplenic T-cell Lymphoma 3.0
CpG dinucleotides introduced into gag can inhibit HIV-1 gene expression by modulating pre-mRNA splicing 2.99
Melanoma therapeutic strategies that select against resistance by exploiting MYC-driven evolutionary convergence 2.97
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells (RNA-Seq) 2.97
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells 2.97
HDAC and NFκB antagonists synergistically inhibit growth and metastatic dissemination of MYC-driven medulloblastoma 2.95
Adaptive chromatin remodeling in glioblastoma stem cell plasticity and drug tolerance 2.94
A global identification of PUM1 and PUM2 mRNA targets and their protein cofactors in human seminoma TCam-2 cells 2.92
The role of TFEB in retinoid induced differentiation of NB4 APL leukemic cells (shTFEB) 2.92
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation 2.84
U1 snRNP telescripting regulates size-function stratified human genome 2.82
Interactions of aCPs with Cytosine-rich Polypyrimidine Tracts Enhance Splicing of Cassette Exons 2.8
Comparative transcriptomic analysis of human and Drosophila extracellular vesicles reveals extensive conservation 2.79
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 2.78
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 (RNA-seq data sets) 2.78
Role of COP1 on MAP kinase transcriptional output in gastrointestinal stromal tumor 2.78
m6A-seq data analysis of control and PCIF1 knockdown transcriptome 2.74
ILF2 Regulates RNA Splicing of DNA Damage Response Genes to Confer Poor Prognosis in 1q21-Amplified Multiple Myeloma 2.72
Transcriptome analysis of AGS cells infected with Helicobacter pylori P12 2.68
Reversible LSD1 Inhibition with HCI-2509 induces the p53 gene expression signature in high-risk neuroblastoma cells 2.65
Nascent RNA Sequencing after NMYC activation in SH-EP MYCNER cells 2.64
mRNA and miRNA expression in primary human muscle cells treated with 1,25(OH)2D3 or vehicle 2.61
RNA expression in primary huamn muscle cells treated with 1,25(OH)2D3 or vehicle 2.61
RNA-seq analysis of control and NRDE2-depleted breast cancer cells 2.61
Control of prostate tumour growth by the long non-coding RNA GHSROS 2.61
A Stable Transcription Factor Complex Nucleated by Dimeric AML1-ETO Controls Leukaemogenesis 2.6
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 1] 2.59
RNA-seq transcriptonal profiling in human primary adult erythroid progenitor cells (ProEs) after shRNA-mediated depletion of TFAM and PHB2 expression 2.58
p38 SAPK and SKIIP induced changes in alternative splicing patterns upon osmostress 2.56
RNA-Guided Human Gene Activation by Cas9/CRISPR-Based Engineered Transcription Factors 2.56
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies [RNA-seq] 2.5
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies 2.5
MLL-AF4 Spreading Identifies Binding Sites that Are Distinct from Super-Enhancers and that Govern Sensitivity to DOT1L Inhibition in Leukemia. 2.48
N6-methyladenine DNA Modification in Glioblastoma [RNA-seq] 2.47
N6-methyladenine DNA Modification in Glioblastoma 2.47
C9orf72 Intermediate Repeats are Associated with Corticobasal Degeneration, Increased C9orf72 Expression and Disruption of Autophagy 2.46
RNA-Seq profiling of day 7 and day 18 kidney organoids differentiated in two batches 2.46
Rational targeting of cooperating layers of the epigenome yields enhanced therapeutic efficacy against AML 2.46
MYC interacts with the G9a histone methyltransferase to drive transcriptional repression and tumorigenesis 2.46
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [K562] 2.44
The regulartory role of ZCCHC24 in splicing machinery 2.43
Transcriptome analysis in Neobractatin treated cells 2.43
A map of gene expression in neutrophil-like cell lines 2.42
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq rescue_SS] 2.41
DJ-1 is dispensable for human stem cell homeostasis 2.41
ADAR1-editing of cellular and measles virus-derived duplex RNA 2.4
ADAR1-editing in HeLa, p150-KO and ADAR1-KO transcriptomes 2.4
Trans-chromosomal regulation by a novel lincRNA required for adipogenesis that escapes X-chromosome inactivation 2.39
Effect of CHKA knockdown on C4-2 cell transcriptome 2.39
Global reduction in H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas 2.38
A TFIID-SAGA perturbation that targets MYB and suppresses acute myeloid leukemia 2.38
A TFIID-SAGA perturbation that targets MYB and suppresses acute myeloid leukemia (RNA-seq) 2.38
The effect of insulin on mRNA transcription of human pluripotent stem cells 2.38
LncPRESS1 is a p53-regulated lncRNA that safeguards pluripotency by disrupting SIRT6 mediated de-acetylation of histone H3K56 2.36
Effect of estrogen (E2) treatment on the C4-12 relative to the MCF7 cells 2.36
RNA-seq in acute myeloid leukemia (AML) cells with and without knockdown of METTL14 2.36
BASP1 modifies the Tamoxifen response 2.36
Genome-wide discovery of human splicing branchpoints [RNAse] 2.35
Combined use of astragalus polysaccharide and berberine attenuates insulin resistance in IR-HepG2 cells via regulation of the gluconeogenesis signaling pathway 2.35
Global transcriptome analysis in the MYCN-amplified neuroblastoma cell line IMR5-75 upon inducible MYCN-knockdown 2.33
Effect of Hotair overexpression in human breast cancer cell lines 2.32
Patient iPSC-derived neural stem cells display progressive enlargement of lysosomes and disruptions of glycosaminoglycan pathway and autophagy in concordance with clinical severity of Mucopolysaccharidosis I 2.29
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 2.29
Dual modulation of neuron specific microRNAs and the REST complex promotes functional maturation of induced human adult neurons 2.28
MDM2 and MDM4 are Therapeutic Vulnerabilities in Malignant Rhabdoid Tumors 2.27
Epigenetic siRNA and chemical screens identify SETD8 inhibition as a new therapeutic strategy of p53 reactivation in high-risk Neuroblastoma. 2.25
Total RNA sequencing of APC mutant and wt colonic organoids 2.25
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 2.25
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 2.25
The evolution of N6-methyladenosine in primates 2.25
Biological effect of chronic mistranslation in mammalian cells 2.23
RNA Sequencing of default, melanocyte biased and enteric human neural crest populations (NC) and neuroectoderm (CNS) 2.23
Zika Virus Has Oncolytic Activity against Glioblastoma Stem Cells 2.21
Neuroligin-4 Regulates Excitatory Synaptic Transmission in Human Neurons 2.2
The cohesin complex prevents Myc-induced replication stress 2.19
A Unique Epigenomic Landscape Defines Human Erythropoiesis 2.17
A Unique Epigenomic Landscape Defines Human Erythropoiesis (RNA-seq) 2.17
RNA seq data of Hep3B-control, Hep3B-sertraline, Hep3B-XL413, Hep3B-XL413-sertraline, Huh7-control, Huh7-sertraline, Huh7-XL413, Huh7-XL413-sertraline cells 2.15
Treatment of multiple myeloma cells with EZH2 small molecule inhibitor 2.15
Induction of Prolonged Early G1 Arrest by CDK4/CDK6 Inhibition Reprograms Lymphoma Cells for Durable PI3Kδ Inhibition Through PIK3IP1 2.14
The WNT target SP5 negatively regulates WNT transcriptional programs in human pluripotent stem cells 2.13
Analysis and expansion of the eosinophilic esophagitis transcriptome by RNA sequencing 2.13
Transcriptional alteration after ionizing radiation exposure in human fibroblasts, iPSCs and NPCs 2.13
Uridylation by TUT4 and TUT7 marks mRNA for degradation [RNA-Seq] 2.13
Genome-wide identification of cancer-specific alternative splicing in circRNA 2.13
Hierarchy of mono- and bi-allelic TP53 alterations in Multiple Myeloma cell fitness 2.12
Next Generation RNA Sequencing Analysis of AMPK Wild Type, AMPKα-KO and AMPKα1-2A U2OS cell Transcriptomes 2.11
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma [RNA-Seq] 2.1
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma 2.1
RNAseq of T-ALL upon long non coding rna purturbation 2.09
RNA-Seq and ATAC-Seq in SMARCD2 k/d NB4 cells with/without ATRA differentiation 2.09
RNA-Seq in SMARCD2 k/d NB4 cells with/without ATRA differentiation 2.09
RNA-sequencing of human mammary epithelial cells (HMLEs) transduced in vitro with a shRNA against SOX4 or a scrambled shRNA in untreated and TGF-β-treated (16 hours) conditions 2.05
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer 2.01
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer (RNA-seq) 2.01
RNA-sequencing with micro-dissected boundary organoid into anterior, posterior, and boundary regions 2.01
Generation of Brain Region-specific Organoids using a Miniaturized Spinning Bioreactor and Modelling ZIKV Exposure 2.01
RNAseq of PRMT4KD in human cord blood derived CD34+ cells 2.0
Modeling the MYC-driven normal-to-tumour switch in breast cancer. 2.0
TAF1 is critical for AE driven leukemogenesis 1.99
TAF1 is critical for AE driven leukemogenesis [RNA-seq] 1.99
RNA-seq of H1299 cells in which either PRKCI or SOX2 was silenced by validated lentiviral shRNA constructs 1.97
RNA-seq analysis of FET cells treated with RSPO1 or TGFβ1 1.97
Global analysis of ZNF217 chromatin occupancy in the breast cancer cell genome reveals an association with Eralpha 1.95
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [MB157_RNA-seq] 1.95
RNA-seq analysis of RALD iPSCs after in vitro differentiation 1.94
Glioma Stem Cell Specific Super Enhancer Drives Polyunsaturated Fatty Acid Synthesis to Support EGFR Signaling 1.93
Diverse AR-V7 cistromes in castration-resistant prostate cancer are governed by HoxB13 1.92
Identification of PRMT5-dependent genes in ESA+CD24lowCD44+ MCF7 cells 1.91
LEDGF and HDGF2, histone H3K36 methyl-binding proteins that assist RNA polymerase II transcription through nucleosomes 1.9
12hr 5-FU treatment vs. DMSO in SJSA cells (from 'A kinase independent role for CDK19 in p53 response') 1.9
Chronic cadmium exposure decreases the dependency of MCF7 breast cancer cells on ERα 1.9
Image based identification and targeting of cancer stem cells in pancreatic adenocarcinoma (PDAC) 1.86
A SIRT1-centered Circuitry Regulates Breast Cancer Stemness and Metastasis 1.85
Human SETMAR is a DNA sequence-specific histone-methylase with a broad effect on the transcriptome 1.85
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq] 1.83
Characterisation of HIF-dependent alternative isoforms in pancreatic cancer 1.82
LncRNA NMR knockdown and overexpression in esophageal squamous cell carcinoma cell lines 1.8
Cell cycle positioning drives heterogeneity within the pluripotent stem cell compartment 1.79
Gene expression profiling of leukemia cells following asparagine depletion 1.79
Next generation sequencing of the transcriptome in MCF-7 cells with/without SRA knockdown 1.77
Global transcriptional profiling changes upon knockdown of LKB1 in human glioblastoma cell lines 1.77
Multiple mechanisms disrupt let-7 miRNA biogenesis and function in neuroblastoma 1.77
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures [RNA-Seq] 1.77
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures 1.77
Tracing Enhancer Networks using Epigenetic Traits (TENET) 1.75
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation [RNA-Seq] 1.75
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation 1.75
Gene target specificity of the Super Elongation Complex (SEC) family: How HIV-1 Tat employs selected SEC members to activate viral transcription 1.74
Identification of global XBP1s target gene expression in human prostate cancer cells 1.72
Transcriptome wide identification of retained introns upon depletion of the splicing factors SNW1 or PRPF8 1.71
The long non-coding RNA MALAT1 contributes to the pathogenesis of multiple sclerosis through alternative splicing and backsplicing regulation 1.71
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer 1.7
Integrin αvβ3 acting as membrane receptor for thyroid hormones mediates angiogenesis in malignant T cells 1.69
circRNA profile in hypopharyngeal cancer 1.67
Smad5 acts as an intracellular pH messenger and maintains bioenergetic homoeostasis 1.66
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells 1.66
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells [RNA-Seq] 1.66
Human stem cell based models of neuronal migration provide insight into neurological disease pathogenesis and potential treatment 1.66
Tunable protein synthesis by transcript isoforms in human cells (Transcript Isoforms in Polysomes sequencing: TrIP-seq) 1.65
HeLa transcriptome induction by IFN gamma and indoleamine 2,3-dioxygenase (IDO) 1.64
Investigsting the role of NF-ĸB p50 S80 phosphorylation in regulating TNFα-induced transcription in HEK293T cells 1.63
RNA splicing alteration on glioblastoma and normal neural stem cells 1.63
Genes significantly down or Up-regulated upon RNF219 knockdown 1.62
Chromatin remodeling mediated by ARID1A is indispensable for normal hematopoiesis in mice (human RNA-Seq) 1.61
Enhancer divergence and cis-regulatory evolution in the human and chimpanzee neural crest 1.61
Transcriptome analysis of human embryonic stem cells (hESCs) upon siRNA-mediated knockdown of hESC-essential genes 1.59
Molecular characterization of BRSK2 and BRSK1 kinases as negative regulators of the NRF2 transcription factor 1.58
The phosphatidylinositol 3-kinase pathway as a potential therapeutic target in bladder cancer 1.56
Analysis of transcrptomes of Danon patient derived hiPSC-cardiomyocytes by RNA-deep Sequencing 1.56
Identification of a dynamic core transcriptional network in t(8;21) AML regulating differentiation block and self-renewal [RNA-Seq] 1.55
Identification of a dynamic core transcriptional network in t(8;21) AML regulating differentiation block and self-renewal 1.55
Integrin signaling regulates YAP/TAZ to control skin homeostasis 1.54
Transcription differences in DLBCL cell lines U2932, DOHH2 on treatment with TK compound compared to DMSO 1.53
Isogenic patient-derived human iPSCs, wild-type or heterozygous for PIK3CA-E418K 1.53
Transcriptomic analysis of iPSC and ESC challenged with atmospheric or physiological oxygen 1.49
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines 1.46
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines [RNA-seq] 1.46
Identification of Sin3B regulated genes during quiescence 1.46
SETBP1-WT and SETBP1-G870S epigenetic landscapes 1.45
SETBP1-WT and SETBP1-G870S transcriptional profiles [RNA-Seq] 1.45
Genome-wide discovery of human splicing branchpoints 1.44
Expression data from A2780 cells treated with DMSO, Olaparib(Ola), Palbociclib(PD), and their combination (Ola/PD) 1.41
An alternative CTCF isoform antagonizes canonical CTCF occupancy and changes chromatin architecture to promote apoptosis 1.41
Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG 1.4
Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG [RNA-seq] 1.4
Interferon-γ Represses M2 Gene Expression in Human Macrophages by Disassembling Enhancers Bound by the Transcription Factor MAF 1.37
IFN-γ Represses M2 Gene Expression in Human Macrophages by Suppressing and Disassembling MAF-binding Enhancers [RNA-seq] 1.37
Knock-down of Ror1 in MDA-MB-231 cell line decreases cell invasiveness 1.37
Distinct Pathological Signatures in Human Cellular Models of Myotonic Dystrophy Subtypes 1.36
Transcriptome profiling of H1-iCas9 cells grown on laminin and on MEFs 1.36
Single amino acid change underlies distinct roles of H2A.Z subtypes in human syndrome 1.36
Next Generation Sequencing Facilitates Quantitative Analysis of mesoderm posterior bHLH transcription factor 1(MESP1)+ and MESP1- cells' Transcriptomes 1.35
Characterization of Type I Interferon pathway during Hepatic Differentiation of Human Pluripotent Stem Cells and hepatitis C virus infection 1.35
Gene expression, methylome and splicing of THP-1 monocytic cells and THP-1-derived macrophage 1.35
Analysis of MGE Transcriptomes with or without Ctnnb1 knockout in human through RNA Sequencing 1.34
RNA-seq of HDAC2-disrupted 293FT cells by CRISPR-Cas9 1.33
CRISPR/Cas9-mediated ASXL1 mutation in U937 cells perturbs myeloid differentiation 1.33
Analysis of chromosomal aberrations and recombination by allelic bias in RNA-Seq 1.3
RNA-Seq data of NCI-H82 cells expressing a Dox-On pRB (pTripZ RB1) grown in the presence or absence of DOX and then treated with vehicle or AZD2811. 1.3
Paclitaxel plus Cirmtuzumab Achieves Greater Clearance of Patient-derived Xenografts By Targeting ROR1+ Breast Cancer Stem Cells 1.28
Genes significantly down or Up-regulated upon RNF219 knockdown. [RNA-Seq] 1.28
iPSC-Derived Cholangiocytes 1.22
Transciptome profiling of NoDice and RNaseIII null cells prior to and after polyIC treatment 1.22
The Wnt/β-catenin and RAS-ERK Pathways were Activated in Tissues of Chemotherapy-Resistant Gastric Cancer PDX Tumor 1.21
RNA sequencing of ESC/iPSC-derived purified PAX6-GFP neural progenitors form control and Phelan-Mcdermid patients 1.21
TrapSeq: An RNA Sequencing-based pipeline for the identification of genetrap insertions in mammalian cells 1.21
RNA sequencing of hiPSC derived neural crest populations from Familial Dysautonomia patients 1.2
SOX17 Is a Critical Specifier of Human Primordial Germ Cell Fate 1.2
PolyA+ RNA-seq in ALL-SIL upon TLX1 knockdown 1.18
Targeting Chromatin Regulators Inhibits Leukemogenic Gene Expression in NPM1 Mutant Leukemia 1.18
Characterization of EZH2-deficient human embryonic stem cells [ChIP-seq and bulk RNA-seq] 1.16
Histone deacetylase inhibition enhances antimicrobial peptide but not inflammatory cytokine expression upon bacterial challenge 1.15
Genome-wide maps of m6A circRNAs identify widespread and cell-type-specific methylation patterns that are distinct from mRNAs 1.14
Genome-wide modelling of transcription kinetics reveals patterns of RNA processing delays 1.13
Functional Haploid Human Oocytes Generated from Polar Body Genomes 1.12
Functional Haploid Human Oocytes Generated from Polar Body Genomes (RNA-Seq) 1.12
DNMT1-associated long non-coding RNA regulate global gene expression and DNA methylation in colon cancer 1.12
RNA-seq of HEK293T cells overexpressing TET1-FL or TET1-ALT 1.11
Gene expression analysis of human haploid cells (HAP1) depleted of SMARCB1 and SMARCA4 1.1
Gene profiling of human adult and pediatric liver cancer cells 1.1
Connexin 32-mediated cell-cell communication is essential for hepatic differentiation from human embryonic stem cells 1.06
Neural cell adhesion molecule 1 (NCAM1; CD56) promotes leukemogenesis and confers drug resistance in acute myeloid leukemia. 1.04
DDX54 regulates transcriptome dynamics during DNA damage response [4SU-seq] 1.04
Multi-omic measurements of heterogeneity in HeLa cells across laboratories 1.03
iPSC derived motor neuron cultures from C9ORF72 carriers 1.02
RNASEQ Analysis of sh-TRC and sh-MIR100HG in the triplex negative breast cancer 1.02
Large-Scale Atlas of Mutant IDH1-Dependent Chromatin State Reprogramming, Reversibility, and Persistence 1.0
Large-Scale Atlas of Mutant IDH1-Dependent Chromatin State Reprogramming, Reversibility, and Persistence [RNA-seq] 1.0
Next Generation Sequencing and m6A sequencing Facilitates Quantitative Analysis of Wild Type and genetic FTO knockdown ccRCC cells Transcriptomes 1.0
Neurofibromin is an Estrogen Receptor alpha Transcriptional Co-repressor in Breast cancer 1.0
Transcriptome analysis of fetal Klinefelter testis tissue samples compared to controls 1.0
Functional interdependency of BRD4 and DOT1L in MLL leukaemia 0.99
RNASeq of MV4;11 cell treated with DMSO, I-BET, SGC0946 and combination of I-BET and SGC0946 0.99
Primate transcript and protein expression levels evolve under compensatory selection pressures 0.97
JAK dependent survival of ALK- ALCL 0.97
Gene expression changes after LOC550643 silencing 0.96
Intrinsic histone acetyltransferase activity of BRD4 is responsible for nucleosome eviction and transcriptional activation 0.95
Mutually Exclusive CBC-Containing Complexes Contribute to RNA Fate. 0.92
RNA sequencing with KSHV infection and enrichment for circular RNAs 0.92
Derivation and differentiation of haploid human embryonic stem cells 0.9
Induced pluripotent stem cell modeling of bone marrow failure and MDS identifies therapeutic targets 0.9
Sodium butyrate ameliorates aSyn-induced transcription deregulation and DNA damage 0.9
RNA sequencing analysis of human embryonic stem cells and axial progenitors 0.9
Myc activation coordinates gene transcription and protein translation responses 0.89
RNA-Seq characterization of human H1-derived NPC differentiation timecourse 0.88
Polarized B -cell functions 0.88
yylncT acts as a gatekeeper of the mesodermal transcriptional program by local modulation of DNMT3B [human_2] 0.85
mRNA recovered upon RNF219 IP. [RNA-IP] 0.85
Huntingtin aggregation impairs autophagy leading to Argonaute-2 accumulation and global microRNA dysregulation 0.84
RNA-seq of naive and primed ES cells 0.79
Small-molecule-based Human Genome G4 Profiling Reveals Potential Gene Regulation Activity 0.76
RNAseq of human monocyte cell line (U937-Cas9) WT or IRF2KO 0.75
Inhibition of the integrin alpha-V beta-3 reverts the paradoxical effect of levothyroxine replacement during bexarotene therapy in cutaneous T-cell lymphoma 0.75
Expression profiles of the four human major ectodermal lineages 0.73
Self-organized cerebral organoids with human specific features predict effective drugs to combat Zika virus infection 0.73
Self-organized cerebral organoids with human specific features predict effective drugs to combat Zika virus infection [RNA-seq] 0.73
HNRNPM-regulated splicing dependencies in prostate cancer 0.69
HNRNPM-regulated splicing dependencies in prostate cancer [RNA-Seq] 0.69
Human Induced Pluripotent Stem Cells Recapitulate Breast Cancer Patients’ Predilection to Doxorubicin-Induced Cardiotoxicity 0.68
RNA-Seq of cKIT+ sorted cells from 53-137 day old fetal testes and ovaries and RNA-Seq of TRA-1-81+ H1 and UCLA1 hESCs. 0.68
cKIT+ sorted cells from 57-137 day old fetal testes and ovaries 0.68
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [ESRP KD] 0.64
Activation of Wnt/beta-catenin in Ewing sarcoma cells antagonizes EWS/ETS function and promotes phenotypic transition to more metastatic cell states 0.64
Human naïve pluripotent stem cells exhibit X chromosome dampening and X-inactivation (RNA-Seq) 0.62
ZEB1 insufficiency causes corneal endothelial cell state transition and altered cellular processing 0.61
Modelling and rescuing neurodevelopmental defect of Down syndrome using induced pluripotent stem cells from monozygotic twins discordant for trisomy 21 0.57
Modelling and rescuing neurodevelopmental defect of Down syndrome using induced pluripotent stem cells from monozygotic twins discordant for trisomy 21 [RNA-seq] 0.57
RNA seq with AML (NB4) cells upon FTO inhibition 0.57
Patient Derived Xenograft for Delivery of Precision Medicine in Castrate Resistant Prostate Cancer 0.56
Research resource: global identification of estrogen receptor β target genes in triple negative breast cancer cells 0.56
CHCHD10 gene KO effect in iPSC drived motor neurons 0.55
Hyper-activation of HUSH complex function by Charcot-Marie-Tooth disease mutation in MORC2 0.55
Transcriptome-wide modulation of splicing by the exon junction complex 0.54
Gene expression from AsPC-1 cells treated with PTC596 and DMSO 0.54
The metabolome regulates the epigenetic landscape during naïve to primed human embryonic stem cell transition 0.52
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML 0.52
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML [RNA-Seq human] 0.52
Role of FGFR1 in neuronal devlopment 0.51
Dynamic developmental signaling logic underlying lineage bifurcations during human endoderm induction and patterning from pluripotent stem cells 0.5
Dynamic developmental signaling logic underlying lineage bifurcations during human endoderm induction and patterning from pluripotent stem cells [Endoderm RNA-seq and ChIP-seq data sets] 0.5
mRNA profiles of JMJD3 overexpression- and JMJD3 knockout- HL-60 cells 0.49
Derivation and differentiation of haploid human embryonic stem cells [RNA-Seq 1] 0.49
Genome wide association study of bone size yields eleven loci that also affect height, bone density, osteoarthritis and fractures 0.48
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 rescue] 0.47
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle 0.47
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle [RNA-seq] 0.47
Activin/Smad2-induced H3K27me3 reduction is crucial to initiate mesendoderm differentiation of ES Cells 0.47
Gene expressions of H9s in different culture systems 0.46
Transcriptome sequencing of K-562 cells 0.46
Fixed tissue ChIP-Seq (FiT-Seq) of archived clinical samples reveals chromatin dynamics and tumor-specific enhancer profiles 0.45
Dissection of estrogen receptor alpha signaling pathways in osteoblasts using RNA-sequencing 0.45
Next Generation Sequencing Facilitates Quantitative Analysis of UVB(20mJ/cm2 and 40mJ/cm2) exposed and untreated HaCaT keratinocytes Transcriptomes 0.44
Functional significance of the HIV-1 Tat signature amino acid residues 0.43
Integrative analysis of microRNAs and mRNAs in liver tissue and exosomes from blood of hepatitis C virus (HCV) related hepatocellular carcinoma (HCC) patient to identify biomarker and regulators of HCC [Total RNA-Seq] 0.42
Integrative analysis of microRNAs and mRNAs in liver tissue and exosomes from blood of hepatitis C virus (HCV) related hepatocellular carcinoma (HCC) patient to identify biomarker and regulators of HCC 0.42
Disease modelling of core pre-mRNA splicing factor haploinsufficiency 0.42
Molecular Criteria for Defining the Naive Human Pluripotent State 0.38
RNAseq of Breast cancer PDX samples 0.37
Transcriptome analysis of SH-SY5Y cells after knockdown of circSLC45A4 0.36
Expression analysis of genes modulated after knock-down of lncRNA CHROME. 0.36
Human ES Cell-derived Hepatoblasts are an Optimal Lineage Stage for HCV Infection 0.36
Next Generation Sequencing Quantitative Analysis of Wild Type and AML1-ETO Related Fusion Circular RNA (F-CircAE) Knockdown Kasumi-1 Cells Transcriptomes 0.35
Transcriptomics analysis of gene expression in normal and METTL3 or WTAP deficient Human HeLa cells 0.34
The CDK7 Inhibitor THZ1 Alters RNA Polymerase Dynamics at the 5’ and 3’ Ends of Genes 0.34
Chronic Myeloid Leukemia (CML), induced pluripotent stem cell (iPSC)-derived lin-CD34+CD45+ (iCD34) cell population 0.33
Tracking transcriptional changes in a species-specific manner during experimental hepatoblastoma progression in vivo 0.33
Transcriptome Analysis Reveals Distinct Responses to Physiologic versus Toxic Manganese Exposure in Human Neuroblastoma Cells 0.33
Illumina HiSeq Sequencing on Breast cancer PDX samples 0.33
The cohesin release factor WAPL restricts chromatin loop extension. 0.31
The cohesin release factor WAPL restricts chromatin loop extension. [RNA-Seq] 0.31
Hepatic transcriptome of pediatric hepatoblastoma. 0.31
Comparison of 7 small cell lung cancer PDX models, cultured ex vivo, for response to LSD1 inhibitor RG6016/ORY1001 0.3
Widespread Transcription beyond mRNA 3’ Ends Yields Abundant Regulatory RNAs 0.29
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies [RNA-seq data set 2] 0.29
Mechanism suppressing H3K9 trimethylation in pluripotent stem cells and its demise by polyQ-expanded huntingtin mutations [RNA-seq] 0.29
Mechanism suppressing H3K9 trimethylation in pluripotent stem cells and its demise by polyQ-expanded huntingtin mutations 0.29
PANCR, the PITX2 adjacent noncoding RNA, is specifically expressed in human left atria and regulates PITX2c expression 0.29
The control of rRNA synthesis during the directed differentiation of human embryonic stem cells precedes heterochromatin formation. 0.28
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer 0.26
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer [RNA-seq] 0.26
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock 0.26
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock [RNA-Seq] 0.26
Gene expression analysis of human hepatocellular cancers 0.25
Profiling of circular RNAs in gastric cancer tissues and adjacent normal tissues 0.25
Epigenomic conservation of transposable element silencing 0.25
Epigenomic conservation of transposable element silencing [RNA-seq] 0.25
Sequencing of freshly produced RNA following exposure of cells to DNA damage-inducing UV mimetic 4-hydroxyaminoquinolone (4-NQO) 0.25
Genomic location of PRMT6-dependent H3R2 methylation is decisive for the transcriptional outcome of associated genes 0.25
Transcriptome analysis of PRMT6 knock-out in NT2/D1 cells 0.25
Activity-dependent transcriptional changes in human neurons 0.21
Genome-wide analysis of the Integrator complex (HTS) 0.2
Genome-wide analysis of the Integrator complex 0.2
CNOT1 and Transcriptomic Landscape of a HeLa Cell Line 0.2
CDK12 mediated transcriptional regulation in U2OS cells 0.2
ELAVL2-regulated transcriptional networks in human neurons link atlernative splicing, autism and human neocortical evolution 0.19
ALS implicated protein TDP-43 sustains levels of STMN2 a mediator of motor neuron growth and repair 0.19
Network-based, cross-cohort discovery of transcriptional mechanisms presiding over maintenance of high-risk neuroblastoma subtype state 0.18
An intramolecular salt bridge linking TDP43’s RNA recognition motifs dictates RNA binding, protein stability and TDP43-dependent neurodegeneration 0.18
Gene expression profiling by RNA-seq of SW480 TGM2 knockdown cells 0.18
Single-Cell RNA Sequencing Reveals Metallothionein Heterogeneity during hESC Differentiation to Definitive Endoderm [RNA-Seq] 0.17
Genome-wide maps of chromatin state and mRNA expression patterns in leukemic cell lines 0.15
GLIS3 Transcriptionally Activates WNT Genes to Promote Differentiation of Human Embryonic Stem Cells to Posterior Neural Progenitors 0.15
RNA sequencing quantitative analysis of RNA editing levels in ADAR1, ADAR2, AIMP2 overexpression and wild type HEK293 cells 0.13
Transcriptional changes after overexpression of proliferation drivers in human mammary epithelial cells. 0.11
Effect of nuclear IL-33 on gene expression 0.11
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) 0.1
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) [RNA-seq] 0.1
Proteomics identifies a marker signature of MAPKi resistance in melanoma 0.08
Identification of trans regulators of ADAR and A-to-I RNA editing using RNA-seq 0.07
Unbiased identification of trans regulators of ADAR and A-to-I RNA editing 0.07
The MEF2B Regulatory Network 0.06
The MEF2B Regulatory Network - RNA-seq data 0.06
Gene expression and genome-wide location analysis of breast cancer cell-lines 0.06
Gene expression analysis of breast cancer cell-lines 0.06
RNAseq analysis of ruxolitinib treated breast cancers 0.05
CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape 0.04
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of HSCe) 0.04
KAP1 regulates ERVs in differentiated human cells and contributes to innate immune control 0.03
Genome-wide search for differentially expressed RNAs responsible for the effects induced by Ebola virus replication and transcription 0.03
5hmC dynamically correlated with enhancer's activities during hES-to-Pancreatic endoderm cell differentiation (RNA-Seq) 0.03
5hmC dynamically correlated with enhancer's activities during hES-to-Pancreatic endoderm cell differentiation 0.03
Glucose inhibits cardiac maturation through nucleotide biosynthesis 0.03
Transcriptome analysis of the HepG2 cells expressing hepatic transcription factors 0.02
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 KO] 0.02
The Small Molecule ISRIB Reverses the Effects of eIF2α Phosphorylation on Translation and Stress Granule Assembly 0.01
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma [RNA-seq] 0.01
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma 0.01
mRNA sequencing of clinical-grade neural stem cells derived from human ES cells 0.01
Epigenome Editing by CRISPR/Cas9 Repressors for Silencing of Distal Regulatory Elements 0.0
The SS18-SSX fusion oncoprotein hijacks BAF complex targeting and function to drive synovial sarcoma [RNA-Seq Tumor] 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation